Somatostatin — CAS 38916-34-6

Somatostatin is a cyclic peptide hormone that inhibits the release of growth hormone, insulin, glucagon, and other hormones. It has therapeutic applications in acromegaly, carcinoid tumors, and gastrointestinal bleeding. Mediocon Inc manufactures GMP-compliant Somatostatin API at its Aurangabad facility to international pharmacopoeial standards.

• Acromegaly treatment
• Carcinoid syndrome management
• Gastrointestinal hemorrhage
• Pituitary tumor suppression

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support